Track 23: Liver Cancer Advancing Innovation and Improving Outcomes in Hepatocellular Carcinoma and Liver Malignancies
The 13th International Cancer and Medical Oncology Conference & Exhibition will be held on February 1–2, 2027 , at the prestigious Novotel Al Barsha, bringing together leading oncologists, hepatologists, surgeons, researchers, healthcare professionals, and industry experts from around the world. Among its specialized scientific sessions, Track 23: Liver Cancer will provide an in-depth platform for discussing the latest developments in liver cancer prevention, diagnosis, treatment, and translational research. Liver cancer remains one of the leading causes of cancer-related mortality worldwide. The increasing incidence of hepatocellular carcinoma (HCC), cholangiocarcinoma, and metastatic liver tumors highlights the urgent need for innovative therapeutic strategies, early detection methods, and multidisciplinary patient management approaches. This dedicated track aims to address these challenges by fostering collaboration among clinicians, researchers, and healthcare stakehold...